National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
oprelvekin (oh-PREL-vuh-KIN)

 A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Oprelvekin is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, recombinant human interleukin-11, and rhIL-11.

Previous Definitions:ophthalmoscope, opiate, opioid, opioid growth factor, opportunistic infection
Next Definitions:OPT-80, optic chiasm, optic chiasma, optic nerve, optic pathway glioma